Codexis, Inc.
Codexis Unveils Pioneering Enzymatic Synthesis Data at TIDES Europe 2024
Company showcases four routes of synthesis for approved siRNA therapeutic asset and demonstrates superiority of double-stranded RNA ligases compared to wild-type enzymes
View Details Here